Chinese english Germany Japanese Korea

Lolamicin

Lolamicin Struktur
2930690-12-1
CAS-Nr.
2930690-12-1
Englisch Name:
Lolamicin
Synonyma:
Lolamicin;3-((3-(4-(2,6-Dimethylpyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)benzonitrile;Benzonitrile, 3-[[3-[4-(2,6-dimethyl-4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-;5-[(4-chlorophenyl)-(4,6-dihydroxy-2-sulfanylpyrimidin-5-yl)methyl]-2-sulfanylpyrimidine-4,6-diol
CBNumber:
CB514273576
Summenformel:
C24H20N4O
Molgewicht:
380.44
MOL-Datei:
2930690-12-1.mol
Request For Quotation

Lolamicin Eigenschaften

Siedepunkt:
566.944±50.00 °C(Press: 760.00 Torr)(predicted)
Dichte
1.279±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka
10.051±0.10(predicted)
Aggregatzustand
Solid
Farbe
Light yellow to yellow

Sicherheit

Lolamicin Chemische Eigenschaften,Einsatz,Produktion Methoden

Lolamicin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Lolamicin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Beckham Medical Technology Co., Ltd 13816613772
 huahero21@sina.com China 2391 55
Wuhan Dingxintong Pharmaceutical Co. , Ltd. 15871722230
 15871722230@163.com China 4686 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 59936 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581
 sales@chemhifuture.com China 5927 58
Shaanxi Istare Biotechnology Co., Ltd. 18682931470; 18682931470
 2142355700@qq.com China 4723 58
TargetMol Chemicals Inc. 15002134094
 marketing@targetmol.cn China 29243 58
Shanghai meikai technology co., ltd 021-68689288 15300790979
 info@mkbio.com.cn China 5000 58
  • Lolamicin
  • Benzonitrile, 3-[[3-[4-(2,6-dimethyl-4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-
  • 3-((3-(4-(2,6-Dimethylpyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)benzonitrile
  • 5-[(4-chlorophenyl)-(4,6-dihydroxy-2-sulfanylpyrimidin-5-yl)methyl]-2-sulfanylpyrimidine-4,6-diol
  • 2930690-12-1
Copyright 2019 © ChemicalBook. All rights reserved